Our experimental data demonstrate that SJB2-043 exerts potent inhibitory effects on the activation of ERK, p38, and JNK, thereby suppressing MAPK-mediated signaling transduction and impeding the progression of NSCLC (Figure 8). This evidence concerns the gene MAPK8 and non-small cell lung carcinoma.